#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Monogenic diabetes Craniocerebral injury Alveolar rhabdomyosarcoma Arteriovenous malformation Neuroendocrine tumour of the lung B precursor type acute leukaemia Ventricular fibrillation Hypoparathyroidism Anti-glomerular basement membrane disease Orthostatic hypotension Leukocyte adhesion deficiency Peripheral T-cell lymphoma unspecified Cholangiosarcoma Hairy cell leukaemia Myotonic dystrophy More trials…

    Learn about Rare Diseases

    Pulmonary fibrosis – Treatment Atypical teratoid/rhabdoid tumour of CNS – Treatment Wiskott-Aldrich syndrome – Diagnostics Rhabdomyosarcoma – Treatment Paroxysmal nocturnal haemoglobinuria Synovial sarcoma metastatic – Basic Information Ewing’s sarcoma – Life with Disease Focal segmental glomerulosclerosis – Treatment Rhabdomyosarcoma – Trials in Disease Pleural mesothelioma malignant – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tisagenlecleucel Omp66 Avibactam Sodium NERANDOMILAST Biotin Terlipressin Acetate Valoctocogene Roxaparvovec Vgl101 Mva-209-Fsp-B2 BRENSOCATIB Ro7589655 Indacaterol Maleate Gad20-209-Fsp-A4 Aavanc80-5'Hotof Pembrolizumab Oditrasertib Anakinra BW-20805 Naporafenib Lisinopril Dihydrate More therapies…

    Learn about Your Condition

    Skin neoplasm excision Renal disorder Coronary artery disease Conjunctivitis Premature baby Arteriosclerosis Ligament operation Infantile apnoea Lupus nephritis Rectal cancer Endocarditis Alexander disease Craniopharyngioma Angiosarcoma recurrent Systemic lupus erythematosus More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on Ketamine for Treating Patients with Severe Brain Injury and Disorders of Consciousness

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Brain injury
    Investigated Drugs:
    • Ketamine
    • Sodium Chloride
    Belgium

  • Study on the Effectiveness of Floxuridine in Patients with Resectable Colorectal Liver Metastases and Low Clinical Risk Score

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Metastases to rectum
    • Colorectal cancer metastatic
    • Colorectal cancer
    The Netherlands

  • Study on Fluconazole and Cefalexin Monohydrate for Treating Laryngeal Leukoplakia in Adults

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Laryngeal leukoplakia
    Investigated Drugs:
    • Cefalexin Monohydrate
    • Fluconazole
    Finland

  • Study of Atezolizumab with BCG Treatment for Patients with High-Risk Non-Muscle Invasive Bladder Cancer Who Have Not Previously Received BCG

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Bladder cancer
    Investigated Drugs:
    • Atezolizumab
    Belgium France Spain

  • Study on the Tolerability and Acceptance of Oral Hydrocortisone for Children with Adrenal Hyperplasia or Adrenal Insufficiency

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Hyperplasia adrenal
    • Primary adrenal insufficiency
    Investigated Drugs:
    • Hydrocortisone Ph. Eur.
    Spain

  • Study on the Effects of Botulinum Toxin A for Improving Arm Function in Patients with Chronic Stroke

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Cerebrovascular accident
    Investigated Drugs:
    • Botulinum Toxin Type A – Haemagglutinin Complex
    France
Previous Page
1 … 843 844 845 846 847 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!